BACKGROUND AND OBJECTIVES: Electronic personal health records (PHRs) allow patients access to their medical records, self-management tools, and new avenues of communication with their health care providers.
FDA issues guidance on antioxidants. The US Food and Drug Administration (FDA) has published guidance to help small companies comply with the labeling of antioxidant products and high potency products. The Small Entity Compliance Guide sets out the agencyâs position âin plain languageâ regarding the use of the nutrient content claims on dietary supplement products.
Anticoagulant and antiplatelet drugs. Definition. Anticoagulants are drugs used to prevent clot formation or to prevent a clot that has formed from enlarging. They inhibit clot formation by blocking the action of clotting factors or platelets. Anticoagulant drugs fall into one of three categories: inhibitors of clotting factor synthesis, inhibitors of thrombin, and antiplatelet drugs.